Chronic Obstructive Pulmonary Disease
Top Cited Papers
- 27 July 2000
- journal article
- review article
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 343 (4), 269-280
- https://doi.org/10.1056/nejm200007273430407
Abstract
Chronic obstructive pulmonary disease (COPD) is characterized by the progressive development of airflow limitation that is not fully reversible.1 The term COPD encompasses chronic obstructive bronchitis, with obstruction of small airways, and emphysema, with enlargement of air spaces and destruction of lung parenchyma, loss of lung elasticity, and closure of small airways. Chronic bronchitis, by contrast, is defined by the presence of a productive cough of more than three months' duration for more than two successive years. The cough is due to hypersecretion of mucus and is not necessarily accompanied by airflow limitation. However, there is some epidemiologic evidence that . . .Keywords
This publication has 99 references indexed in Scilit:
- Tumour necrosis factor-α gene promoter polymorphism in chronic obstructive pulmonary diseaseEuropean Respiratory Journal, 2000
- Serial measurements of exhaled nitric oxide during exacerbations of chronic obstructive pulmonary diseaseEuropean Respiratory Journal, 1999
- Effects of formoterol in apparently poorly reversible chronic obstructive pulmonary diseaseEuropean Respiratory Journal, 1999
- Effect of temperature on lung function and symptoms in chronic obstructive pulmonary diseaseEuropean Respiratory Journal, 1999
- Tiotropium (SPIRIVA™): Mechanistical considerations and clinical profile in obstructive lung diseaseLife Sciences, 1999
- Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysemaThe Lancet, 1997
- Effect of long-term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemiaThorax, 1997
- Noninvasive ventilatory support does not facilitate recovery from acute respiratory failure in chronic obstructive pulmonary diseaseEuropean Respiratory Journal, 1996
- MR889, a neutrophil elastase inhibitor, in patients with chronic obstructive pulmonary disease: a double-blind, randomized, placebo-controlled clinical trialEuropean Respiratory Journal, 1996
- Chest Illness in Infancy and Chronic Respiratory Disease in Later Life: An Analysis by Month of BirthInternational Journal of Epidemiology, 1994